The effects of bupropion alone and combined with naltrexone on weight loss: a systematic review and meta-regression analysis of randomized controlled trials

• Published in: Diabetology and metabolic syndrome Vol. 16; no. 1; pp. 93 - 12
• Main Authors: Liu, Yang, Han, Fei, Xia, Zefeng, Sun, Ping, Rohani, Pejman, Amirthalingam, Palanisamy, Sohouli, Mohammad Hassan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 24.04.2024; BioMed Central; BMC
• Subjects: Analysis; Bias; Body mass index; Body weight loss; Bupropion; Chronic illnesses; Clinical trials; Endorphins; Feedback; Meta-analysis; Naltrexone; Narcotics; Obesity; Overweight; Public health; Regression analysis; Standard deviation; Subject heading schemes; Systematic review; Weight control; Weight loss; Obesity; Bupropion; Naltrexone; Weight loss; Meta-analysis
• ISSN: 1758-5996; 1758-5996
• DOI: 10.1186/s13098-024-01319-7

The global prevalence of obesity and overweight is a significant concern in the field of public health. However, addressing and combating these conditions pose considerable challenges. Numerous interventional studies have been conducted to assess the possible impact of bupropion on weight reduction. The primary objective of this study was to conduct a comprehensive investigation into the effects of bupropiona alone and in combination with naltrexone on weight, body mass index (BMI), and waist circumferences (WC). A systematic search was conducted in five databases using established keywords. The purpose of this search was to uncover controlled trials that examined the impact of bupropion, either as a standalone intervention or in combination with naltrexone, on weight loss outcomes. The random-effects model analysis was used to provide pooled weighted mean difference and 95% confidence intervals. Twenty five studies with 22,165 participants' were included in this article. The pooled findings showed that bupropion administration has an effect on lowering weight (WMD: -3.67 kg, 95% CI: -4.43 to -2.93) and WC (WMD: -2.98 cm, 95% CI -3.78 to -2.19) in compared with control groups. The analysis also showed that the effects of the present intervention on weight and WC during the intervention are > 26 weeks and ≤ 26 weeks compared to the other group, respectively. In addition, changes in weight loss and WC after receiving bupropion together with naltrexone were more compared to bupropion alone. In conclusion, the addition of combination therapies like bupropion and naltrexone to lifestyle modifications including diet would cause significant weight loss.